These results are in full agreement with a previous study reporting that interferon‐β/Ifnar1 signaling has potent immunomodulatory effects in experimental autoimmune encephalomyelitis (EAE), a model for autoimmune brain inflammation and multiple sclerosis (Prinz et al, 2008). This evidence concerns the gene IFNAR1 and multiple sclerosis.